š”š²šš š¦ššŗšŗš®šæš
ā¢ Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited have joined forces through a licensing and supply agreement to co-market Saroglitazar Mg in India for Non-Alcoholic Steato Hepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD).
ā¢ Torrent will compensate Zydus with upfront licensing fees and milestone payments linked to predefined achievements.
ā¢ Saroglitazar Mg is the first approved drug for NASH and NAFLD in any country and has been effective in managing these diseases since its launch in 2013.